Business Wire

2024 Design Intelligence Award Ceremony Hölls med Storslagenhet

Dela

2024 års ceremoni för Design Intelligence Award (DIA) ägde rum den 6 december vid Kina Academy of Art Liangzhu Campus. Fourier General-Purpose Humanoid Robot GR-1 vann det största hederspriset – Grand Prize. THETA Dental Implant Surgery Robot System, Digital Central Axis: Immersive Interactive Digital Exhibition of Beijing's Central Axis, Pic Copilot och Ventete aH-1 Helmet (Storbritannien) mottog Guldpriser.

Detta pressmeddelande använder multimedia. Se den fullständiga versionen här: https://www.businesswire.com/news/home/20241215711252/sv/

2024 Design Intelligence Award Ceremony Hölls med Storslagenhet (Graphic: Business Wire)

Design Intelligence Award (DIA) grundades 2015 och är det första internationella akademiska priset inom industridesign i Kina. Med kärnvärdena "Humanistisk Intellekt, Livets Visdom, Industriellt Think Tank och Vetenskap-Konst Intelligens" har det framgångsrikt hållits i nio upplagor. DIA strävar efter professionalism, internationell prägel och perspektiv, vilket gör det till den mest inflytelserika tävlingen för industridesign i Kina och en viktig global plattform för att diskutera intelligent design och innovativ visdom.

Den nuvarande upplagan av DIA lanserades officiellt den 15 december 2023 och har tagit emot över 8 000 bidrag från 47 länder och regioner världen över, med sju nya deltagande länder och en representation från 76 länder och regioner för första gången. Bland bidragen tilldelades 360 verk från 21 länder och regioner priser, varav 39 framstående verk gick till final. Det är värt att notera att 58% av de utvalda verken inte har släppts på marknaden ännu, och 56% gör sin globala debut. Årets bidrag reflekterar den globala mångfalden och det interkulturella utbytet i den samtida eran, och täcker banbrytande tillämpningar inom artificiell intelligens, hjärn-dator-gränssnitt, virtuell verklighet, nya material och mer. De utforskar aktivt nya områden som förstärkt verklighet och symbios mellan människa och maskin inom framväxande industrier som lågflygsekonomi, digitalt kulturarvsturism och humanoidrobotik, vilket främjar omstrukturering och uppgradering av globala leveranskedjor, innovationskedjor och värdekedjor i industrins 4.0-era.

Officiell webbplats:https://www.di-award.org

Se källversionen på businesswire.com: https://www.businesswire.com/news/home/20241215711252/sv/

Kontakter

Media contact
Contact: Meng Jia
Company Name: Design Intelligence Award
Website: https://www.di-award.org -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.di-award.o
rg&esheet=54165841&newsitemid=20241215711252&lan=sv-SE&anchor=https%3A%2F%2Fwww.
di-award.org&index=2&md5=9d7a9e2a64cda7807eb8d3fe046657db
Email: media@di-award.org

Följ Business Wire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från Business Wire

Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release

Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release

The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th

Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release

Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor

Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release

Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not

BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye